Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biovail to market Novartis’ heart drug in Canada
Lescol and Lescol XL are indicated for the treatment of hypercholesterolemia and mixed hyperlipidemia in conjunction with a diet low in saturated fat and cholesterol. Lescol is also
Lescol and Lescol XL are indicated for the treatment of hypercholesterolemia and mixed hyperlipidemia in conjunction with a diet low in saturated fat and cholesterol. Lescol is also
This move represents the first triptan that can be given without a prescription in the UK and highlights the government's commitment to expand the range of medicines available
The study enrolled 12 treatment-naive patients with genotype 1 HCV who received VX-950 in a tablet formulation at a dose of 750mg every eight hours for 28 days
Lentiviral vectors (LV) are vehicles that can deliver genes or RNAi into cells with a high level of efficiency and stability. By comparison, other viral vector systems such
It has been estimated that, in developed countries, up to 80 % of the cancers of the mouth, pharynx and oesophagus are caused by smoking and alcohol drinking.
On October 18, 2005, the FDA issued an approvable letter for muraglitazar requesting additional information on the drug's cardiovascular safety profile. The company determined that in order to
The trial was a placebo-controlled study of the drug candidate, HCV-796, administered orally for 14 days to patients with chronic hepatitis C virus (HCV) infection who were naive
Remicade is a genetically engineered monoclonal antibody that reduces inflammation by blocking the action of tumor necrosis factor-alpha. The drugwas initially approved in 1998 to treat Crohn’s disease
According to Shire, the application filed by Corepharma for 100mg, 200mg and 300mg versions of the product infringe two patents that have not yet expired. Meanwhile, the FDA
The committee's guidance will be considered by the FDA as it decides whether or not to approve the vaccine. The FDA is not bound by the committee's guidance,